New insights into antigen specific immunotherapy for chronic myeloid leukemia
Y Li, C Lin, CA Schmidt - Cancer cell international, 2012 - Springer
Chronic myeloid leukemia (CML) is a stem cell disease in which BCR/ABL plays an
important role as an oncoprotein and a molecular and immunogenic target. Despite the …
important role as an oncoprotein and a molecular and immunogenic target. Despite the …
Immunology of chronic myeloid leukemia: current concepts and future goals
V Vonka, M Petráčková - Expert Review of Clinical Immunology, 2015 - Taylor & Francis
Although chronic myeloid leukemia is a rare malignancy, it has developed into a model
system for the study of a variety of aspects of cancer biology and immunology. The …
system for the study of a variety of aspects of cancer biology and immunology. The …
Expression and distribution of PPP2R5C gene in leukemia
H Zheng, Y Chen, S Chen, Y Niu, L Yang, B Li… - Journal of hematology & …, 2011 - Springer
Background Recently, we clarified at the molecular level novel chromosomal translocation t
(14; 14)(q11; q32) in a case of Sézary syndrome, which caused a rearrangement from …
(14; 14)(q11; q32) in a case of Sézary syndrome, which caused a rearrangement from …
Decreased level of recent thymic emigrants in CD4+ and CD8+ T cells from CML patients
Y Li, S Geng, Q Yin, S Chen, L Yang, X Wu, B Li… - Journal of translational …, 2010 - Springer
Background T-cell immunodeficiency is a common feature in cancer patients, which may
relate to initiation and development of tumor. Based on our previous finding, to further …
relate to initiation and development of tumor. Based on our previous finding, to further …
Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations
L Xu, YH Lu, J Lai, W Yu, YK Zhang, ZY Jin… - Science China Life …, 2015 - Springer
Diversity in the T cell receptor (TCR) repertoire provides a miniature defense ability for the T
cell immune system that may be related to tumor initiation and progression. Understanding …
cell immune system that may be related to tumor initiation and progression. Understanding …
Deficiency of CD3gamma, delta, epsilon, and zeta expression in T cells from AML patients
S Chen, X Zha, L Yang, B Li, Z Liye, Y Li - Hematology, 2011 - Taylor & Francis
In order to elucidate the feature of T‐cell receptor (TCR) signal transduction in T‐cells from
acute myeloid leukemia (AML), the expression levels of CD3gamma, delta, epsilon and zeta …
acute myeloid leukemia (AML), the expression levels of CD3gamma, delta, epsilon and zeta …
Pediatric T-cell prolymphocytic leukemia with an isolated 12 (p13) deletion and aberrant CD117 expression
M Bellone, AM Svensson, AL Zaslav, S Spitzer… - … hematology & oncology, 2012 - Springer
T-cell Prolymphocytic leukemia (T-PLL) is a rare post-thymic T-cell malignancy that follows
an aggressive clinical course. The classical presentation includes an elevated white blood …
an aggressive clinical course. The classical presentation includes an elevated white blood …
[PDF][PDF] INFLUENCIA DE LOS POLIMORFISMOS GENÉTICOS EN LA LEUCEMIA MIELOIDE CRÓNICA
DJCH Boluda - 2015 - core.ac.uk
EN LA LEUCEMIA MIELOIDE CRÓNICA”, presentado por Dña. Paula Amat Martínez para
optar al Grado de Doctor por la Universidad de Valencia, ha sido realizado bajo su …
optar al Grado de Doctor por la Universidad de Valencia, ha sido realizado bajo su …
Imatinib/interferon-α Acute lymphoblastic leukaemia: case report
L Wang - Reactions, 2010 - Springer
At the age of 10 years, the girl was diagnosed with chronic myeloid leukaemia and started
receiving interferon-α 1.5 MU/day. About 4.5 years later, the interferon-α dose was increased …
receiving interferon-α 1.5 MU/day. About 4.5 years later, the interferon-α dose was increased …